Literature DB >> 22453962

α7 nicotinic ACh receptors as a ligand-gated source of Ca(2+) ions: the search for a Ca(2+) optimum.

Victor V Uteshev1.   

Abstract

The spatiotemporal distribution of cytosolic Ca(2+) ions is a key determinant of neuronal behavior and survival. Distinct sources of Ca(2+) ions including ligand- and voltage-gated Ca(2+) channels contribute to intracellular Ca(2+) homeostasis. Many normal physiological and therapeutic neuronal functions are Ca(2+)-dependent, however an excess of cytosolic Ca(2+) or a lack of the appropriate balance between Ca(2+) entry and clearance may destroy cellular integrity and cause cellular death. Therefore, the existence of optimal spatiotemporal patterns of cytosolic Ca(2+) elevations and thus, optimal activation of ligand- and voltage-gated Ca(2+) ion channels are postulated to benefit neuronal function and survival. Alpha7 nicotinic -acetylcholine receptors (nAChRs) are highly permeable to Ca(2+) ions and play an important role in modulation of neurotransmitter release, gene expression and neuroprotection in a variety of neuronal and non-neuronal cells. In this review, the focus is placed on α7 nAChR-mediated currents and Ca(2+) influx and how this source of Ca(2+) entry compares to NMDA receptors in supporting cytosolic Ca(2+) homeostasis, neuronal function and survival.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22453962      PMCID: PMC3584641          DOI: 10.1007/978-94-007-2888-2_27

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  258 in total

1.  Neuronal death enhanced by N-methyl-D-aspartate antagonists.

Authors:  C Ikonomidou; V Stefovska; L Turski
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Profile of nicotinic acetylcholine receptor agonists ABT-594 and A-582941, with differential subtype selectivity, on delayed matching accuracy by young monkeys.

Authors:  Jerry J Buccafusco; Alvin V Terry; Michael W Decker; Murali Gopalakrishnan
Journal:  Biochem Pharmacol       Date:  2007-07-14       Impact factor: 5.858

3.  Mg2+ imparts NMDA receptor subtype selectivity to the Alzheimer's drug memantine.

Authors:  Shawn E Kotermanski; Jon W Johnson
Journal:  J Neurosci       Date:  2009-03-04       Impact factor: 6.167

4.  Potentiation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.

Authors:  Gareth T Young; Ruud Zwart; Alison S Walker; Emanuele Sher; Neil S Millar
Journal:  Proc Natl Acad Sci U S A       Date:  2008-09-12       Impact factor: 11.205

5.  Functional characterization of the novel neuronal nicotinic acetylcholine receptor ligand GTS-21 in vitro and in vivo.

Authors:  C A Briggs; D J Anderson; J D Brioni; J J Buccafusco; M J Buckley; J E Campbell; M W Decker; D Donnelly-Roberts; R L Elliott; M Gopalakrishnan; M W Holladay; Y H Hui; W J Jackson; D J Kim; K C Marsh; A O'Neill; M A Prendergast; K B Ryther; J P Sullivan; S P Arneric
Journal:  Pharmacol Biochem Behav       Date:  1997 May-Jun       Impact factor: 3.533

6.  Rat nicotinic ACh receptor alpha7 and beta2 subunits co-assemble to form functional heteromeric nicotinic receptor channels.

Authors:  Serguei S Khiroug; Patricia C Harkness; Patricia W Lamb; Sterling N Sudweeks; Leonard Khiroug; Neil S Millar; Jerrel L Yakel
Journal:  J Physiol       Date:  2002-04-15       Impact factor: 5.182

7.  Effects of scopolamine on matching to sample paradigm and related tests in human subjects.

Authors:  G Koller; W Satzger; M Adam; M Wagner; N Kathmann; M Soyka; R Engel
Journal:  Neuropsychobiology       Date:  2003       Impact factor: 2.328

8.  An allosteric modulator of alpha7 nicotinic receptors, N-(5-Chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea (PNU-120596), causes conformational changes in the extracellular ligand binding domain similar to those caused by acetylcholine.

Authors:  Sean C Barron; James T McLaughlin; Jennifer A See; Vanessa L Richards; Robert L Rosenberg
Journal:  Mol Pharmacol       Date:  2009-05-01       Impact factor: 4.436

9.  Relative tolerability of Alzheimer's disease treatments.

Authors:  Gustavo Alva; Jeffrey L Cummings
Journal:  Psychiatry (Edgmont)       Date:  2008-11

10.  Monovalent and divalent cation permeability and block of neuronal nicotinic receptor channels in rat parasympathetic ganglia.

Authors:  T J Nutter; D J Adams
Journal:  J Gen Physiol       Date:  1995-06       Impact factor: 4.086

View more
  24 in total

1.  Activation of α7 nicotinic acetylcholine receptors increases intracellular cAMP levels via activation of AC1 in hippocampal neurons.

Authors:  Qing Cheng; Jerrel L Yakel
Journal:  Neuropharmacology       Date:  2015-04-29       Impact factor: 5.250

2.  High therapeutic potential of positive allosteric modulation of α7 nAChRs in a rat model of traumatic brain injury: proof-of-concept.

Authors:  Joshua W Gatson; James W Simpkins; Victor V Uteshev
Journal:  Brain Res Bull       Date:  2015-01-31       Impact factor: 4.077

3.  Identification of α7 Nicotinic Acetylcholine Receptor Silent Agonists Based on the Spirocyclic Quinuclidine-Δ2 -Isoxazoline Scaffold: Synthesis and Electrophysiological Evaluation.

Authors:  Marta Quadri; Carlo Matera; Almin Silnović; Maria Chiara Pismataro; Nicole A Horenstein; Clare Stokes; Roger L Papke; Clelia Dallanoce
Journal:  ChemMedChem       Date:  2017-06-12       Impact factor: 3.466

4.  Proteomic Investigation of Murine Neuronal α7-Nicotinic Acetylcholine Receptor Interacting Proteins.

Authors:  Matthew J Mulcahy; Joao A Paulo; Edward Hawrot
Journal:  J Proteome Res       Date:  2018-10-04       Impact factor: 4.466

5.  A positive allosteric modulator of α7 nAChRs augments neuroprotective effects of endogenous nicotinic agonists in cerebral ischaemia.

Authors:  Bopanna I Kalappa; Fen Sun; Stephen R Johnson; Kunlin Jin; Victor V Uteshev
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

Review 6.  The effect of α7 nicotinic receptor activation on glutamatergic transmission in the hippocampus.

Authors:  Qing Cheng; Jerrel L Yakel
Journal:  Biochem Pharmacol       Date:  2015-07-23       Impact factor: 5.858

Review 7.  Therapeutic potential of α7 nicotinic acetylcholine receptor agonists to combat obesity, diabetes, and inflammation.

Authors:  Han Xie; Natesh Yepuri; Qinghe Meng; Ravi Dhawan; Colin A Leech; Oleg G Chepurny; George G Holz; Robert N Cooney
Journal:  Rev Endocr Metab Disord       Date:  2020-08-26       Impact factor: 6.514

8.  Curcumin Acts as a Positive Allosteric Modulator of α7-Nicotinic Acetylcholine Receptors and Reverses Nociception in Mouse Models of Inflammatory Pain.

Authors:  Eslam Gaber El Nebrisi; Deniz Bagdas; Wisam Toma; Halima Al Samri; Anna Brodzik; Yasmin Alkhlaif; Keun-Hang Susan Yang; Frank Christopher Howarth; Imad M Damaj; Murat Oz
Journal:  J Pharmacol Exp Ther       Date:  2018-01-16       Impact factor: 4.030

9.  Novel 5-(quinuclidin-3-ylmethyl)-1,2,4-oxadiazoles to investigate the activation of the α7 nicotinic acetylcholine receptor subtype: Synthesis and electrophysiological evaluation.

Authors:  Marta Quadri; Almin Silnović; Carlo Matera; Nicole A Horenstein; Clare Stokes; Marco De Amici; Roger L Papke; Clelia Dallanoce
Journal:  Eur J Med Chem       Date:  2018-10-11       Impact factor: 6.514

10.  The dual effect of PNU-120596 on α7 nicotinic acetylcholine receptor channels.

Authors:  Bopanna I Kalappa; Victor V Uteshev
Journal:  Eur J Pharmacol       Date:  2013-09-11       Impact factor: 4.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.